IP Library › Granted Patent US 7,897,578
Granted Patent B2
US 7,897,578 · App. 12/304,746 · Granted Mar 1, 2011

Peptides with anti-proliferative activity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,578
App. No.
12/304,746
Granted
Mar 1, 2011
Kind
B2
Abstract

The present invention relates to peptides with anti-proliferative activity, of sequence SEQ ID No. 1, SEQ ID No. 2 or SEQ ID No. 3.

Claims (17)

1. An isolated peptide comprising the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, wherein said peptide consists of at most 30 amino acid residues.

2. The peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of SEQ ID NO: 1.

3. The peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of SEQ ID NO: 2.

4. The peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of SEQ ID NO: 3.

5. The peptide of claim 1 , wherein the peptide is an amide peptide.

6. The peptide of claim 5 , wherein the carboxyl terminus of said peptide comprises an amide.

7. An isolated peptide consisting of SEQ ID NO: 1.

8. An isolated peptide consisting of SEQ ID NO: 2.

9. An isolated peptide consisting of SEQ ID NO: 3.

10. A medicament comprising at least one peptide according to claim 1 .

11. A medicament comprising the peptide according to claim 7 .

12. A medicament comprising the peptide according to claim 8 .

13. A medicament comprising the peptide according to claim 9 .

14. A pharmaceutical composition comprising at least one peptide according to claim 1 .

15. A pharmaceutical composition comprising the peptide according to claim 7 .

16. A pharmaceutical composition comprising the peptide according to claim 8 .

17. A pharmaceutical composition comprising the peptide according to claim 9 .

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED ON REEL 023640 FRAME 0166. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 23, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Reel/Frame 038772/0729 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 023638 FRAME: 0555. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded May 23, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 038779/0043 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME. NEED TO ADD S.A.S. TO END OF NAME IPSEN PHARMA. CORRECT NAME SHOULD SHOW AS IPSEN PHARMA S.A.S. PREVIOUSLY RECORDED ON REEL 023638 FRAME 0555. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT NAME SHOULD SHOW AS IPSEN PHARMA S.A.S.. Recorded Jan 12, 2010
From: S.C.R.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 023763/0615 →
CHANGE OF NAME Recorded Dec 11, 2009
From: S.C.R.A.S.
To: IPSEN PHARMA
Reel/Frame 023638/0555 →
CHANGE OF ADDRESS Recorded Dec 11, 2009
From: S.C.R.A.S.
To: S.C.R.A.S.
Reel/Frame 023640/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2009
From: FERRANDIS, ERIC; CAMARA Y FERRER, JOSE-ANTONIO; MARIN, JEAN-GREGOIRE
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
Reel/Frame 022073/0017 →